For appointments, please call:
(303) 823-4882
Major Depressive Disorder (MDD) is a leading cause of disability worldwide. Despite a plethora of established treatments, less than one-third of individuals with MDD achieve stable remission of symptoms. Given limited efficacy and significant lag time to onset of therapeutic action among conventional antidepressants, interest has shifted to treatments that act outside of the monoamine...
We were honored to be recently featured recently in The Denver Post, at https://www.denverpost.com/2022/12/24/ketamine-infusions-depression-chronic-pain-colorado. It is always beneficial when…
Measures to contain the spread of coronavirus have inadvertently increased teen depression and suicide risk, as demonstrated by Mayne…
A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her…
Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…
Many of our ketamine therapy patients tell us that the COVID-19 pandemic is causing a dramatic increase in their…